Current Report Filing (8-k)
June 14 2017 - 12:25PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form
8-K
Current Report Pursuant to Section 13 or
15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 14, 2017
MEDICINE MAN TECHNOLOGIES, INC.
(Exact name of small business issuer as
specified in its charter)
Nevada
|
000-55450
|
46-5289499
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer ID No.)
|
4880 Havana Street
Suite 201
Denver, Colorado 80239
(Address of principal executive offices)
(303) 371-0387
(Issuer’s Telephone Number)
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
Medicine Man Technologies Inc. (OTCQB:
MDCL), one of the country's leading cannabis branding and consulting companies provided an update today regarding its second quarter
interim activity.
Item 9.01 Financial Statements and Exhibits
EX-99.1 - Press Release dated June
14, 2017 regarding update on 2nd quarter interim activity
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MEDICINE MAN TECHNOLOGIES, INC.
|
|
(Registrant)
|
|
|
Dated: June 14, 2017
|
By:
|
s/ Brett Roper
|
|
|
Brett Roper,
Chief Executive Officer
|
Medicine Man Technologies (CE) (USOTC:SHWZ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medicine Man Technologies (CE) (USOTC:SHWZ)
Historical Stock Chart
From Sep 2023 to Sep 2024